Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 5, 2009, Pages 574-583

  Urano, Wako ^a   Furuya, Takefumi ^a   Inoue, Eisuke ^a   Taniguchi, Atsuo ^a   Urano, Tomohiko ^b   Kotake, Shigeru ^a   Sekita, Chieko ^a   Inoue, Satoshi ^b   Hara, Masako ^a   Momohara, Shigeki ^a   Kamatani, Naoyuki ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fracture; Methotrexate; MTHFR; Polymorphism; Rheumatoid arthritis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CORTICOSTEROID DERIVATIVE; METHOTREXATE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FRACTURE; GENE FREQUENCY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED QUESTIONNAIRE; VERTEBRA FRACTURE;

AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHOTREXATE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SPINAL FRACTURES;

EID: 68949101614     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0073-7     Document Type: Article

References (56)

1. C Cooper C Coupland M Mitchell 1995 Rheumatoid arthritis, corticosteroid therapy and hip fracture Ann Rheum Dis 54 49 52
2. TM Huusko M Korpela P Karppi V Avikainen H Kautiainen R Sulkava 2001 Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland Ann Rheum Dis 60 521 522
3. RE Orstavik G Haugeberg P Mowinckel A Hoiseth T Uhlig JA Falch JI Halse E McCloskey TK Kvien 2004 Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls Arch Intern Med 164 420 425
4. K Arai T Hanyu H Sugitani T Murai J Fujisawa K Nakazono N Kondo N Endo 2006 Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study J Bone Miner Metab 24 118 124
5. T Furuya S Kotake E Inoue Y Nanke T Yago M Hara T Tomatsu N Kamatani H Yamanaka 2008 Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study J Bone Miner Metab 26 499 505
6. T Furuya S Kotake E Inoue Y Nanke T Yago T Kobashigawa N Ichikawa E Tanaka S Momohara A Nakajima M Hara T Tomatsu H Yamanaka N Kamatani 2007 Risk factors associated with incident clinical vertebral and nonvertebral fractures in Japanese women with rheumatoid arthritis: a prospective 54-month observational study J Rheumatol 34 303 310
7. JR Hooyman LJ Melton III AM Nelson WM O'Fallon BL Riggs 1984 Fractures after rheumatoid arthritis. A population-based study Arthritis Rheum 27 1353 1361
8. A Nampei J Hashimoto J Koyanagi T Ono H Hashimoto N Tsumaki T Tomita K Sugamoto N Nishimoto T Ochi H Yoshikawa 2008 Characteristics of fracture and related factors in patients with rheumatoid arthritis Mod Rheumatol 18 170 176
9. TP van Staa P Geusens JW Bijlsma HG Leufkens C Cooper 2006 Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis Arthritis Rheum 54 3104 3112
10. DE Furst JM Kremer 1988 Methotrexate in rheumatoid arthritis Arthritis Rheum 31 305 314
11. K Maenaut R Westhovens J Dequeker 1996 Methotrexate osteopathy, does it exist? J Rheumatol 23 2156 2159
12. SJ Preston T Diamond A Scott MR Laurent 1993 Methotrexate osteopathy in rheumatic disease Ann Rheum Dis 52 582 585
13. M Rudler J Pouchot F Paycha S Gentelle A Grasland P Vinceneux 2003 Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis Ann Rheum Dis 62 588 589
14. D Shapira Y Scharf 1995 Insufficiency fracture of the distal tibia mimicking arthritis in a rheumatoid arthritis patient. The possible role of methotrexate treatment Clin Exp Rheumatol 13 130 131
15. LM Buckley ES Leib KS Cartularo PM Vacek SM Cooper 1997 Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis J Rheumatol 24 1489 1494
16. O di Munno M Mazzantini L Sinigaglia G Bianchi G Minisola M Muratore R la Corte L di Matteo B Canesi M Caminiti M Broggini S Adami 2004 Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study J Rheumatol 31 1305 1309
17. P Vestergaard L Rejnmark L Mosekilde 2006 Methotrexate, azathioprine, cyclosporine, and risk of fracture Calcif Tissue Int 79 69 75
18. M Devoto C Specchia HH Li J Caminis A Tenenhouse H Rodriguez LD Spotila 2001 Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36 Hum Mol Genet 10 2447 2452
19. P Frosst HJ Blom R Milos P Goyette CA Sheppard 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113
20. NM van der Put F Gabreels EM Stevens JA Smeitink FJ Trijbels TK Eskes LP van den Heuvel HJ Blom 1998 A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62 1044 1051
21. A Taniguchi W Urano E Tanaka S Furihata S Kamitsuji E Inoue M Yamanaka H Yamanaka N Kamatani 2007 Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice Pharmacogenet Genomics 17 383 390
22. W Urano A Taniguchi H Yamanaka E Tanaka H Nakajima Y Matsuda H Akama Y Kitamura N Kamatani 2002 Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses Pharmacogenetics 12 183 190
23. B Abrahamsen JS Madsen CL Tofteng L Stilgren EM Bladbjerg SR Kristensen K Brixen L Mosekilde 2003 A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study J Bone Miner Res 18 723 729
24. X Hong YH Hsu H Terwedow G Tang X Liu S Jiang X Xu X Xu 2007 Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women Bone (NY) 40 737 742
25. HL Jorgensen JS Madsen B Madsen MM Saleh B Abrahamsen M Fenger JB Lauritzen 2002 Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women Calcif Tissue Int 71 386 392
26. M Shiraki T Urano T Kuroda M Saito S Tanaka M Miyao-Koshizuka S Inoue 2008 The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures J Bone Miner Metab 26 595 602
27. MM Villadsen MH Bunger M Carstens L Stenkjaer BL Langdahl 2005 Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD Osteoporos Int 16 411 416
28. H Yamanaka S Tohma 2006 Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice Mod Rheumatol 16 75 76
29. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi T Saito M Hara T Tomatsu N Kamatani 2003 Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3, 763 patients with rheumatoid arthritis Arthritis Rheum 49 784 788
30. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324
31. ML Prevoo MA van't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48
32. Z Chen M Maricic TL Bassford M Pettinger C Ritenbaugh AM Lopez DH Barad M Gass MS Leboff 2005 Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study Arch Intern Med 165 552 558
33. JA Kanis F Borgstrom C De Laet H Johansson O Johnell B Jonsson A Oden N Zethraeus B Pfleger N Khaltaev 2005 Assessment of fracture risk Osteoporos Int 16 581 589
34. AH Ragab RS Frech TJ Vietti 1970 Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission Cancer (Phila) 25 580 585
35. C Bologna L Edno JM Anaya F Canovas M Vanden Berghe C Jorgensen M Galtier B Combe F Bressolle J Sany 1994 Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients Arthritis Rheum 37 1770 1773
36. GE Friedlaender RB Tross AC Doganis JM Kirkwood R Baron 1984 Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model J Bone Joint Surg [Am] 66 602 607
37. KP May SG West MT McDermott WE Huffer 1994 The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats Arthritis Rheum 37 201 206
38. R Uehara Y Suzuki Y Ichikawa 2001 Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy J Rheumatol 28 251 256
39. Y Segawa M Yamaura S Aota T Omata N Tuzuike Y Itokazu H Oka H Tamaki T Nakamura 1997 Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats Bone (NY) 20 457 464
40. CJ Haagsma HJ Blom PL van Riel MA van't Hof BA Giesendorf D van Oppenraaij-Emmerzaal LB van de Putte 1999 Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 58 79 84
41. CG Gjesdal SE Vollset PM Ueland H Refsum HE Meyer GS Tell 2007 Plasma homocysteine, folate, and vitamin B12 and the risk of hip fracture: the Hordaland homocysteine study J Bone Miner Res 22 747 756
42. RR McLean PF Jacques J Selhub KL Tucker EJ Samelson KE Broe MT Hannan LA Cupples DP Kiel 2004 Homocysteine as a predictive factor for hip fracture in older persons N Engl J Med 350 2042 2049
43. JB van Meurs RA Dhonukshe-Rutten SM Pluijm M van der Klift R de Jonge J Lindemans LC de Groot A Hofman JC Witteman JP van Leeuwen MM Breteler P Lips HA Pols AG Uitterlinden 2004 Homocysteine levels and the risk of osteoporotic fracture N Engl J Med 350 2033 2041
44. DJ Kim JM Koh O Lee NJ Kim YS Lee YS Kim JY Park KU Lee GS Kim 2006 Homocysteine enhances apoptosis in human bone marrow stromal cells Bone (NY) 39 582 590
45. B Raposo C Rodriguez J Martinez-Gonzalez L Badimon 2004 High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells Atherosclerosis 177 1 8
46. B Lubec S Fang-Kircher T Lubec HJ Blom GH Boers 1996 Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria Biochim Biophys Acta 1315 159 162
47. M Saito K Fujii K Marumo 2006 Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls Calcif Tissue Int 79 160 168
48. M Shiraki T Kuroda S Tanaka M Saito M Fukunaga T Nakamura 2008 Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures J Bone Miner Metab 26 93 100
49. Y Sato Y Honda J Iwamoto T Kanoko K Satoh 2005 Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial JAMA 293 1082 1088
50. A de Bree WM Verschuren AL Bjorke-Monsen NM van der Put SG Heil FJ Trijbels HJ Blom 2003 Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample Am J Clin Nutr 77 687 693
51. MC Lodder Z de Jong PJ Kostense ET Molenaar K Staal AE Voskuyl JM Hazes BA Dijkmans WF Lems 2004 Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density Ann Rheum Dis 63 1576 1580
52. DG Seeley WS Browner MC Nevitt HK Genant JC Scott SR Cummings 1991 Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group Ann Intern Med 115 837 842
53. Z Chen C Kooperberg MB Pettinger T Bassford JA Cauley AZ LaCroix CE Lewis S Kipersztok C Borne RD Jackson 2004 Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials Menopause 11 264 274
54. E Siris P Miller E Barrett-Connor T Abbott L Sherwood M Berger 1998 Design of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal women Osteoporos Int 8 suppl 1 S62 S69
55. D Kiel 1995 Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures J Bone Miner Res 10 518 523
56. A Angeli G Guglielmi A Dovio G Capelli D de Feo S Giannini R Giorgino L Moro A Giustina 2006 High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study Bone (NY) 39 253 259